1. Home
  2. KOP vs OABI Comparison

KOP vs OABI Comparison

Compare KOP & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koppers Holdings Inc.

KOP

Koppers Holdings Inc.

HOLD

Current Price

$46.27

Market Cap

784.7M

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$4.63

Market Cap

696.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOP
OABI
Founded
1988
2012
Country
United States
United States
Employees
N/A
89
Industry
Forest Products
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
784.7M
696.4M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
KOP
OABI
Price
$46.27
$4.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
★ $52.50
$4.50
AVG Volume (30 Days)
132.0K
★ 1.4M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
★ 0.90%
N/A
EPS Growth
★ 11.38
6.56
EPS
N/A
★ N/A
Revenue
★ $1,879,300,000.00
$18,666,000.00
Revenue This Year
$2.91
$52.42
Revenue Next Year
$1.86
$64.69
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$25.00
$1.32
52 Week High
$53.00
$5.43

Technical Indicators

Market Signals
Indicator
KOP
OABI
Relative Strength Index (RSI) 50.01 58.15
Support Level $44.40 $1.86
Resistance Level $48.14 $5.43
Average True Range (ATR) 1.20 0.24
MACD 0.06 -0.02
Stochastic Oscillator 52.41 64.71

Price Performance

Historical Comparison
KOP
OABI

About KOP Koppers Holdings Inc.

Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: